Kaydiar

Kaydiar specializes in developing advanced offloading technology designed to alleviate pressure lesions, particularly for diabetic foot care. The company targets healthcare providers, diabetic patients, and sports enthusiasts who require effective solutions for pressure-induced wounds. Operating within the medical device market, Kaydiar employs a business model that focuses on the innovation and sale of modular, silicone insoles. These insoles, branded as ZeroSole, can be easily adapted to fit conventional and surgical footwear, providing long-term pressure reduction and improved patient outcomes. Revenue is generated through direct sales and partnerships with healthcare institutions. Kaydiar's mission is to improve patient outcomes and reduce the financial burden on healthcare systems by offering next-generation medical devices.

Keywords: offloading technology, pressure lesions, diabetic foot care, medical devices, ZeroSole, modular insoles, healthcare innovation, patient outcomes, cost reduction, biomechanics.